Are there gender differences in colorectal cancer test use prevalence and correlates?
Are there gender differences in colorectal cancer test use prevalence and correlates?
复制标题
DOI：
10.1158/1055-9965.epi-05-0629
复制
发表时间：
2006-04-01
影响因子：
3.8
通讯作者：
Rakowski, W
中科院分区：
文献类型：
--
作者：
McQueen, A;Vernon, SW;Rakowski, W
尽管有证据表明筛查可以降低结直肠癌的发病率和死亡率，但筛查的普及率很低。在测试吸收的性别差异已被报道，但很少有研究检查的相关性测试使用的性别。差异，如果存在，可能会告知策略，以增加测试的使用。我们使用2002年至2003年健康信息全国趋势调查的数据，研究了结肠直肠癌检查使用[粪便潜血试验（FOBT）和内窥镜检查]的患病率和相关性的性别差异。男性（n = 999）和女性（n = 1687）受访者年龄>= 50岁，没有结直肠癌的个人病史，通过电话采访。按性别和检测类型报告了终生使用、近期使用和重复使用的经统计学调整的患病率。多变量逻辑回归分析用于确定按性别和结直肠癌检测类型分层的检测使用的相关性。更多的女性报告在一生中和过去一年中仅使用FOBT，而更多的男性报告重复使用内窥镜检查。其他测试或测试组合的使用没有性别差异。两种性别的结直肠癌检测使用一致的正相关因素包括年龄，最近的医生就诊，最近的乳腺癌或前列腺癌筛查，以及对特定检测筛查间隔的了解。不同性别的相关因素包括比较感知风险，认为结直肠癌检测过于昂贵，害怕发现结直肠癌，以及关注和信任健康信息的媒体来源。这种差异，如果在未来的研究中得到证实，可能会告知使用性别特异性干预策略或信息，以增加结直肠癌检测的使用。
Despite evidence that screening tests reduce colorectal cancer incidence and mortality, screening prevalence is low. Gender differences in test uptake have been reported, but few studies examine correlates of test use by gender. Differences, if present, may inform strategies to increase test use. We examined gender differences in the prevalence and correlates of colorectal cancer test use [fecal occult blood test (FOBT) and endoscopy] using data from the 2002 to 2003 Health Information National Trends Survey. Male (n = 999) and female (n = 1687) respondents ages >= 50 years, without a personal history of colorectal cancer, were interviewed by telephone. Age-adjusted prevalence rates were reported for lifetime, recent, and repeat use by gender and test type. Multivariable logistic regression analyses were used to identify correlates of test use stratified by gender and colorectal cancer test type. More females reported only using FOBT in lifetime and in the past year, whereas more males reported repeat endoscopy use. The use of other tests or combinations of tests did not differ by gender. Consistent positive correlates of colorectal cancer test use for both genders included age, recent physician visits, recent breast or prostate cancer screening, and knowledge of test-specific screening intervals. Correlates that differed by gender included comparative perceived risk, belief that colorectal cancer testing was too expensive, fear of finding colorectal cancer if tested, and attention to and trust in media sources of health information. Such differences, if confirmed in future studies, may inform the use of gender-specific intervention strategies or messages to increase colorectal cancer test use.